from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3075c/-

LFCtreatmentdescriptionclass of inhibitor

0.391

Amikacinug/mL Amikacintranslation

0.726

Cap5-10ug/mL Capreomycintranslation

0.550

Rox10-50 ug/mL Roxithromycintranslation

0.800

SM2-5 ug/mL Streptomycintranslation

0.954

Tet5-10 ug/mL Tetracyclinetranslation

-1.073

Rif0.2-5ug/mL Rifampicintranscription

-0.425

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.651

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.101

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.811

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.034

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.249

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.991

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.900

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.077

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.779

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.843

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.026

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.192

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.363

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.467

KCN5-20 ug/mL Potassium cyaniderespiration

-0.009

NaN30.2-2 mM Sodium aziderespiration

-0.537

Nigericin50 uM Nigericinrespiration

-0.151

TRC10-150 ug/mL Triclosanrespiration

-0.818

TRZ10-25 ug/mL Thioridazinerespiration

-0.446

Valinomycin0.5-10 uM Valinomycinrespiration

-0.708

ZnSO42 mM ZnSO4respiration

-0.288

menadione6-10 ug/mL Menadionerespiration

-0.821

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.276

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.717

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.623

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.015

NRP_1Non-replicating persistence stage 1dosRassociated

-0.372

Amp0.2mg/mL AmpicillincellWall

-0.350

Cephalexin20-100 ug/mL CephalexincellWall

-0.114

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.111

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.569

EMB10-20 ug/mL EthambutolcellWall

0.122

Eta12-40 ug/mL EthionamidecellWall

0.357

INH0.2-0.4 ug/mL IsoniazidcellWall

0.006

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.479

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.745

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.137

BZA0.12 mg/mL BenzamidearomaticAmides

1.394

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

2.037

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.065

H2O24 mM hydrogen peroxideDNAdamaging

-0.243

Levo10 ug/mL LevofloxacinDNAdamaging

-0.266

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.506

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.075

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.690

UVUV-irradiationDNAdamaging

-0.842

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.260

Antimycin12.5-50 ug/mL Antimycin A?

-0.428

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.425

PA_110-50 ug/mL Antitubercular compound PA-1?

0.070

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.427

PA8240.2-2 ug/mL PA-824?

0.908

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.435

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.906

Verapamil50 uM Verapamil?

-0.340

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.369

methoxatin10-20 ug/mL Methoxatin?